Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 14;22(1):648.
doi: 10.1186/s12913-022-08060-9.

Mental health care for rare disease in the UK - recommendations from a quantitative survey and multi-stakeholder workshop

Affiliations

Mental health care for rare disease in the UK - recommendations from a quantitative survey and multi-stakeholder workshop

Rosa Spencer-Tansley et al. BMC Health Serv Res. .

Abstract

Background: Rare disease patients and carers report significant impacts on mental health but studies on UK populations have focussed on relatively few, specific conditions. Collectively rare conditions represent a substantial health burden, with an estimated 3.5 million affected individuals in the UK.

Method: We explored the impact on mental health of living with a rare condition, and experiences of health service support, through an online survey. The survey assessed the impact of specific experiences commonly reported by those affected by a rare condition through multiple choice questions and Likert scale items, and open text question boxes. Through a multi-stakeholder workshop that involved facilitated discussion of our findings with patients/carers, clinicians and a government advisor, we developed recommendations for policy and practice toward a more person-centred and integrated approach.

Results: Eligible responses came from 1231 patients and 564 carers. Due to their rare condition, the majority of respondents (> 90%) had felt worried/anxious; stressed; and /or low/depressed. Thirty-six percent of patients and 19% of carers had had suicidal thoughts. Challenges that are particular to rare conditions and which negatively affect mental health included limited knowledge of the condition amongst healthcare professionals (88%), and not being believed or taken seriously by them. Only 23% of respondents felt healthcare professionals considered mental and physical health as equally important. Almost half reported never having been asked about mental health by healthcare professionals. Our findings indicate that access to, and appropriateness of, professional psychological support needs to be improved. Peer group support is important but signposting is inadequate. Our recommendations are for healthcare professionals to be supported to effectively and sensitively recognise and address patients' and carers' mental health needs; and for service level coordination of care to integrate professional psychological support with rare disease services.

Conclusion: Living with a rare disease substantially impacts mental health. Many of the drivers of poor mental health reflect issues specific to managing rare conditions. To meet UK government commitments, there should be a focus on empowering healthcare professionals who treat rare disease patients and on integration of mental health support with rare disease services.

Keywords: Health service; Mental health; Patient experience; Rare disease; Recommendations; Survey; Undiagnosed.

PubMed Disclaimer

Conflict of interest statement

The authors have no competing interests to declare.

Figures

Fig. 1
Fig. 1
Flow chart of project methods
Fig. 2
Fig. 2
Emotions attributed to living with a rare condition (percent of respondents: patients and carers combined)
Fig. 3
Fig. 3
“The following things have had a negative impact on my emotional health and wellbeing”. Panel A shows the extent to which respondents agree that interactions with healthcare professionals have had a negative impact (percent of respondents, patients and carers combined). Panel B shows the extent to which respondents agree that interactions with services have had a negative impact (percent of respondents, patients and carers combined)
Fig. 4
Fig. 4
Evaluation of physical vs mental health services, and parity of esteem. Panel A shows respondents’ rating of physical vs mental health services. Panel B shows the level of agreement with physical and mental health having parity of esteem. Both panels show percent of respondents, patients and carers combined
Fig. 5
Fig. 5
“Discussions about mental health and wellbeing with healthcare professionals … ”. Percent of respondents that agreed or strongly agreed with the statements; patients and carers combined
Fig. 6
Fig. 6
Evaluation of professional psychological support received. Extent to which respondents agreed with statements about the support received. Percent of respondents, patients and carers combined
Fig. 7
Fig. 7
Ways in which other sources of support are helpful. Percent of respondents who agreed or strongly agreed with answers to the question “How has this support been helpful to you?”. Patients and carers combined

Similar articles

Cited by

References

    1. EU Research on rare diseases. https://ec.europa.eu/info/research-and-innovation/research-area/health-r.... Accessed 20 Dec 2021.
    1. Commission of the European Communities. Communication from the commission to the European Parliament, the council, the European economic and social committee and the Committee of the Regions on rare diseases. Europe's Challenges; 2008. https://ec.europa.eu/health/ph_threats/non_com/docs/rare_com_en.pdf. Accessed 20 Dec 2021.
    1. Shire. Rare disease impact report: insights from patients and the medical community. Jersey: Shire; 2013.
    1. Genetic Alliance UK . Rare Experience 2020. The lived experiences of people affected by genetic, rare and undiagnosed conditions. Genetic Alliance UK; 2020.
    1. Anderson M, Elliott EJ, Zurynski YJ. Australian families living with rare disease: experiences of diagnosis, health services use and needs for psychosocial support. Orphanet J Rare Dis. 2013;8:22. doi: 10.1186/1750-1172-8-22. - DOI - PMC - PubMed